HANLON SUZANNE M. (Sec, VP & General Counsel) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/25/2021ACC: 0001192482-21-000110
Officer· Sec, VP & General Counsel
Since Aug 2018
+92K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
92K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+37K
Price / share
—
Trade value
—
% of position
84.7%
1/21/2021
43.69K→80.69K
Total
Net shares
+37K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2021 | A · Award | +37K | — | — | 84.7% | 43.69K | 80.69K |
| Total | +37K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
55K shares
Shares
+55K
Strike price
3.58
Held after
55K
Exercisable
—
1/21/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock55K shares | 1/21/2021 | A · Award | +55K | 3.58 | — | 55K |